Personalis is a biotechnology company dedicated to transforming cancer management through personalized testing solutions. The company utilizes advanced genomic profiling and proprietary algorithms to provide clinicians with comprehensive insights that guide patient care from biopsy through treatment. Personalis offers highly sensitive assays designed to detect minimal residual disease and recurrence, facilitating the selection of targeted therapies and improving biomarker strategies for drug development. Based in Fremont, California, Personalis aims to enhance the standard of care in oncology by delivering actionable information that adapts as cancer evolves, ultimately supporting patients throughout their cancer journey.